Detalhe da pesquisa
1.
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
N Engl J Med
; 388(18): 1645-1656, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133584
2.
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 566(7745): E13, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733620
3.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 565(7738): 240-245, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568303
4.
PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer.
Int J Gynecol Cancer
; 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184318
5.
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer.
Breast Cancer Res Treat
; 193(3): 567-577, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441273
6.
Real-world evaluation of supportive care using an electronic health record text-mining tool: G-CSF use in breast cancer patients.
Support Care Cancer
; 30(11): 9181-9189, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044088
7.
Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer.
Support Care Cancer
; 30(8): 6947-6953, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543818
8.
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Support Care Cancer
; 30(8): 6641-6648, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501515
9.
Perceptions of Japanese and Dutch women with early breast cancer about monitoring their quality of life.
J Psychosoc Oncol
; 40(4): 527-540, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34266363
10.
Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.
Int J Cancer
; 149(5): 1181-1188, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043821
11.
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Breast Cancer Res Treat
; 185(3): 741-758, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179154
12.
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.
Gynecol Oncol
; 161(3): 727-733, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712276
13.
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
Am J Obstet Gynecol
; 225(4): 407.e1-407.e16, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019887
14.
Psychosocial determinants of adherence with oral anticancer treatment: 'we don't need no education'.
Acta Oncol
; 60(1): 87-95, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151764
15.
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
Br J Cancer
; 122(10): 1453-1460, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203207
16.
Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies.
Oncologist
; 25(2): e341-e350, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043782
17.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat
; 180(3): 675-685, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124136
18.
Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
Int J Gynecol Cancer
; 30(1): 115-121, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31744889
19.
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 20(6): 862-876, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076365
20.
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 21(1): 97, 2019 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455425